Erlotinib Terminated Phase 1 Trials for Neuroendocrine Tumors / Renal Cell Adenocarcinoma / Non-Small Cell Lung Carcinoma (NSCLC) / Neoplasm Metastases Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01115803A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors